Y-27632 (hydrochloride) Ancillary Material
Product Description
Cayman Chemical Company
-
Country/Region:United States
-
Founded:1980
-
On CPHI since:2021
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Cayman Chemical Company
-
Country/Region:United States
-
Founded:1980
-
On CPHI since:2021
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
More Products from Cayman Chemical Company (20)
-
Product GMP SM-102
M-102 is manufactured as an excipient suitable for use in LNP preparation and small molecule encapsulation at Cayman Chemical in Ann Arbor, MI. GMP material appropriate for clinical trials is available. (NOTE: This product is subject to licensing for use in commercial applications.) -
Product GMP Tafluprost
Tafluprost is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Tafluprost is available for customer review upon request. The DMF has been filed with the US FDA and in Russia. -
Product GMP Travoprost
Travoprost is manufactured at Cayman Pharma, our Czech subsidiary. GMP material, which conforms to the USP Monograph, is available. The DMF is on file with the US FDA, Canada, India, Japan, China, in several EU member states, and in several other countries. -
Product GMP Y-27632 (hydrochloride) Ancillary Material
This product has been manufactured and tested in accordance with GMP principles set forth by the ICH and FDA and meets the expectations for commercial cell, gene, and tissue-engineered products in accordance with USP <1043> "Ancillary Materials for Cell, Gene, and Tissue-engineered Products.
qq... -
Product IWR-1-endo Ancillary Material
This product has been tested in accordance with GMP principles and meets the expectations for clinical cell, gene, and tissue-engineered products in accordance with USP <1043> “Ancillary Materials for Cell, Gene, and Tissue-engineered Products”.
WARNING This product is not for human or vet... -
Product Process Development Services
Our team of highly skilled chemists specialize in fit-for-purpose route design of complex, multi-step organic syntheses. They leverage the extensive capabilities and diverse chemistry experience of Cayman Chemical to improve process development and accelerate innovation. Our team embraces a quality by desi... -
Product Bucladesine (sodium salt) Ancillary Material
This product has been tested in accordance with GMP principles and meets the expectations for clinical cell, gene, and tissue-engineered products in accordance with USP <1043> “Ancillary Materials for Cell, Gene, and Tissue-engineered Products”.
WARNING This product is not for human or veter... -
Product DAPT Ancillary Material
This product has been tested in accordance with GMP principles and meets the expectations for clinical cell, gene, and tissue-engineered products in accordance with USP <1043> “Ancillary Materials for Cell, Gene, and Tissue-engineered Products”.
WARNING This product is not for human or veter... -
Product GMP (+)-Cloprostenol sodium salt
(+)-Cloprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the ASMF for (+)-Cloprostenol sodium salt is on file in the UK, Switzerland, and in most EU countries. -
Product GMP (±)-Cloprostenol sodium salt
(±)-Cloprostenol sodium salt is manufactured at Cayman Pharma, our Czech subsidiary. GMP material, which conforms to the USP and BVP Monographs, is available. The DMF is on file with the US FDA, Canada, Russia, in almost all EU member states, and in many other countries. -
Product GMP (−)-(R)-Methamphetamine (hydrochloride)
(-)-(R)-Methamphetamine (hydrochloride) is manufactured at Cayman Chemical in Ann Arbor, MI. GMP material appropriate for clinical trials is available. -
Product GMP 3,4-MDMA
3,4-MDMA is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is under development.